Compare Cloudflare Inc (NET) vs Organon & Co. Common Stock (OGN) Price & Performance

Cloudflare (NET) trades at $347.76, down 0.83% on the day but remains near recent highs with strong technical momentum. The company shows impressive revenue growth from $975M in 2022 to $2.17B in 2025, though profitability remains elusive with negative net margins. Recent product launches including Basin data platform and post-quantum certificate authority demonstrate continued innovation, while analyst sentiment remains strongly positive with 71% buy ratings.

While Cloudflare demonstrates robust revenue growth and strategic positioning in cloud security, investors face valuation concerns with P/S of 48.7 and persistent negative profitability. The stock's upside depends on continued enterprise adoption and eventual path to profitability, but high valuation multiples create vulnerability to any growth deceleration. Key risks include competitive pressure and the challenge of converting growth into sustainable earnings.

Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.

OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.